Abstract:Background Breast cancer is the most common type of invasive cancer in woman. It accounts for approximately 18% of all cancer deaths worldwide. It is well known that somatic mutation plays an essential role in cancer development. Hence, we propose that a prognostic prediction model that integrates somatic mutations with gene expression can improve survival prediction for cancer patients and also be able to reveal the genetic mutations associated with survival. Method Differential expression analysis was used to identify breast cancer related genes. Genetic algorithm (GA) and univariate Cox regression analysis were applied to filter out survival related genes. DAVID was used for enrichment analysis on somatic mutated gene set. The performance of survival predictors were assessed by Cox regression model and concordance index(C-index). Results We investigated the genome-wide gene expression profile and somatic mutations of 1091 breast invasive carcinoma cases from The Cancer Genome Atlas (TCGA). We identified 118 genes with high hazard ratios as breast cancer survival risk gene candidates (log rank p < 0.0001 and c-index = 0.636). Multiple breast cancer survival related genes were found in this gene set, including FOXR2 , FOXD1 , MTNR1B and SDC1 . Further genetic algorithm (GA) revealed an optimal gene set consisted of 88 genes with higher c-index (log rank p < 0.0001 and c-index = 0.656). We validated this gene set on an independent breast cancer data set and achieved a similar performance (log rank p < 0.0001 and c-index = 0.614). Moreover, we revealed 25 functional annotations, 15 gene ontology terms and 14 pathways that were significantly enriched in the genes that showed distinct mutation patterns in the different survival risk groups. These functional gene sets were used as new features for the survival prediction model. In particular, our results suggested that the Fanconi anemia pathway had an important role in breast cancer prognosis. Conclusions Our study indicated that the expression levels of the gene signatures remain the effective indicators for breast cancer survival prediction. Combining the gene expression information with other types of features derived from somatic mutations can further improve the performance of survival prediction. The pathways that were associated with survival risk suggested by our study can be further investigated for improving cancer patient survival.

Towards key genes identification for breast cancer survival risk with neural network models

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Identification of gene regulatory networks associated with breast cancer patient survival using an interpretable deep neural network model

Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer

A Novel Coiled-Coil Domain Containing-Related Gene Signature for Predicting Prognosis and Treatment Effect of Breast Cancer.

Integrative Analysis Based on Survival Associated Co-Expression Gene Modules for Predicting Neuroblastoma Patients' Survival Time

An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer

Network-based Survival Analysis to Discover Target Genes for Developing Cancer Immunotherapies and Predicting Patient Survival.

An Integrated Model of Clinical Information and Gene Expression for Prediction of Survival in Ovarian Cancer Patients

Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis

Classical statistical methods are powerful for the identification of novel targets for the survival of breast cancer patients

Identifying Oncogenes As Features for Clinical Cancer Prognosis by Bayesian Nonparametric Variable Selection Algorithm

Gene expression profiling of breast cancer survivability by pooled cDNA microarray analysis using logistic regression, artificial neural networks and decision trees

Identification of Key Genes in Non-Small Cell Lung Cancer by Bioinformatics Analysis

Survival Prediction Across Diverse Cancer Types Using Neural Networks

Identification of Key Candidate Genes, Pathways and Related Prognostic Values in ER-negative/HER2-negative Breast Cancer by Bioinformatics Analysis.

Uncovering the Prognostic Gene Signatures for the Improvement of Risk Stratification in Cancers by Using Deep Learning Algorithm Coupled with Wavelet Transform

Network-Based Inference Framework for Identifying Cancer Genes from Gene Expression Data

Prediction and interpretation of cancer survival using graph convolution neural networks

Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning

Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis